Corvidia Therapeutics
United StatesWho owns Corvidia Therapeutics?
Corvidia Therapeutics is an American Biotech company, now owned by Novo Nordisk, which acquired it in 2020 from Sofinnova Partners and Andera Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2020 to Novo Nordisk.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
Sofinnova Partners sold Corvidia Therapeutics to Novo Nordisk in 2020 after 4 years.
Andera Partners sold Corvidia Therapeutics to Novo Nordisk in 2020 after 2 years.
More from BioDiscovery 5
Other portfolio companies in the same fund.
France· 2021
France· 2021
Belgium· 2020
France· 2019
Netherlands· 2019
Switzerland· 2019More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Corvidia Therapeutics?
Corvidia Therapeutics is now owned by Novo Nordisk, which acquired it in 2020 from Sofinnova Partners and Andera Partners.
When did Novo Nordisk acquire Corvidia Therapeutics?
Novo Nordisk acquired Corvidia Therapeutics in 2020, buying from Sofinnova Partners and Andera Partners.
Who did Corvidia Therapeutics sell to?
Sofinnova Partners and Andera Partners sold Corvidia Therapeutics to Novo Nordisk in 2020 (Trade Sale).
Who has owned Corvidia Therapeutics over time?
Corvidia Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital VIII · 2016–2020 · sold to Novo Nordisk · (Trade Sale); Andera Partners · via BioDiscovery 5 · 2018–2020 · sold to Novo Nordisk · (Trade Sale).